skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Dual chain synthetic heparin-binding growth factor analogs

Patent ·
OSTI ID:1040008

The invention provides synthetic heparin-binding growth factor analogs having two peptide chains each branched from a branch moiety, such as trifunctional amino acid residues, the branch moieties separated by a first linker of from 3 to about 20 backbone atoms, which peptide chains bind a heparin-binding growth factor receptor and are covalently bound to a non-signaling peptide that includes a heparin-binding domain, preferably by a second linker, which may be a hydrophobic second linker. The synthetic heparin-binding growth factor analogs are useful as pharmaceutical agents, soluble biologics or as surface coatings for medical devices.

Research Organization:
Brookhaven National Laboratory (BNL), Upton, NY (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
AC02-98CH10886
Assignee:
BioSurface Engineering Technologies, Inc. (Rockville, MD)
Patent Number(s):
8,163,717
Application Number:
12/574,484
OSTI ID:
1040008
Country of Publication:
United States
Language:
English

References (116)

Trans-repressor activity of nuclear glycosaminoglycans on Fos and Jun/AP-1 oncoprotein-mediated transcription journal January 1992
Preferential antagonism of the interactions of the integrin αIIbβ3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins journal December 1994
A heparin binding synthetic peptide from human HIP / RPL29 fails to specifically differentiate between anticoagulantly active and inactive species of heparin journal February 2003
A Novel Isoform of Human Fibroblast Growth Factor 8 Is Induced by Androgens and Associated with Progression of Esophageal Carcinoma journal January 2001
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia journal May 2001
FGF Signaling Controls Somite Boundary Position and Regulates Segmentation Clock Control of Spatiotemporal Hox Gene Activation journal July 2001
Enhanced osteogenic promotion around dental implants with synthetic binding motif mimicking bone morphogenetic protein (BMP)-2 journal January 2006
Identification of a Human Type II Receptor for Bone Morphogenetic Protein-4 That Forms Differential Heteromeric Complexes with Bone Morphogenetic Protein Type I Receptors journal September 1995
Computational Complexity, Protein Structure Prediction, and the Levinthal Paradox book January 1994
The challenges of genome sequence annotation or “The devil is in the details” journal November 1997
Induction of Osteogenic Differentiation by Hedgehog Proteins journal August 1997
Engineering of an FGF–proteoglycan fusion protein with heparin-independent, mitogenic activity journal June 2000
Amino-terminal sequences of a novel heparin-binding protein from human, bovine, rat, and chick brain: High interspecies homology journal April 1990
Multidomain Synthetic Peptide B2A2 Synergistically Enhances BMP-2 In Vitro journal November 2004
The Heparin-Binding (Fibroblast) Growth Factor Family of Proteins journal June 1989
Heparin-Binding EGF-like Growth Factor: Characterization of Rat and Mouse cDNA Clones, Protein Domain Conservation across Species, and Transcript Expression in Tissues journal January 1993
Fgf-19, a Novel Fibroblast Growth Factor with Unique Specificity for Fgfr4 journal October 1999
Polymeric system for dual growth factor delivery journal November 2001
αvβ3 Integrin Mediates the Cell-adhesive Capacity and Biological Activity of Basic Fibroblast Growth Factor (FGF-2) in Cultured Endothelial Cells journal December 1997
A 10-amino acid sequence of fibroblast growth factor 2 is sufficient for its mitogenic activity on neural progenitor cells journal June 1997
RGD motif enhances immunogenicity and adjuvanicity of peptide antigens following intranasal immunization journal December 2003
Characterization of heparin-binding growth-associated factor receptor on NIH 3T3 cells journal January 1992
Genomic structure, mapping, activity and expression of fibroblast growth factor 17 journal May 1999
Novel Branching Membrane Translocational Peptide as Gene Delivery Vector journal November 2002
Receptor- and heparin-binding domains of basic fibroblast growth factor. journal April 1988
Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. journal May 1993
Structure and Expression of a Novel Fibroblast Growth Factor, FGF-17, Preferentially Expressed in the Embryonic Brain journal March 1998
Silyl-heparin bonding improves the patency and in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts journal May 2004
Ear rings: FGF3 involvement comes full circle journal August 2000
Overlapping Expression and Redundant Activation of Mesenchymal Fibroblast Growth Factor (FGF) Receptors by Alternatively Spliced FGF-8 Ligands journal February 1997
Bone Morphogenetic Protein Receptor Complexes on the Surface of Live Cells: A New Oligomerization Mode for Serine/Threonine Kinase Receptors journal March 2000
Structure and Expression of a Novel Member, FGF-16, of the Fibroblast Growth Factor Family journal February 1998
Cloning of a Novel Type II Serine/Threonine Kinase Receptor through Interaction with the Type I Transforming Growth Factor-β Receptor journal March 1995
Identification of a novel FGF, FGF-21, preferentially expressed in the liver journal June 2000
The Spemann Organizer Signal noggin Binds and Inactivates Bone Morphogenetic Protein 4 journal August 1996
Controlling TGF-β signaling journal March 2000
Clinical and Radiographic Outcomes of Anterior Lumbar Interbody Fusion Using Recombinant Human Bone Morphogenetic Protein-2 journal January 2002
Biosynthesis of human fibroblast growth factor-5. journal April 1991
Molecular cloning of a novel cytokine cDNA encoding the ninth member of the fibroblast growth factor family, which has a unique secretion property. journal July 1993
Directly Linked Soluble il-6 Receptor–Il-6 Fusion Protein Induces Astrocyte Differentiation from Neuroepithelial Cells via Activation of Stat3 journal March 2001
Structural and functional characterization of full-length heparin-binding growth associated molecule. journal January 1992
Interleukin 1 regulates heparin-binding growth factor 2 gene expression in vascular smooth muscle cells. journal January 1991
Gene Expression During Autograft Lumbar Spine Fusion and the Effect of Bone Morphogenetic Protein 2 journal January 1998
Adenovirus-mediated transfer of the HST-1 (FGF4) gene induces increased levels of platelet count in vivo. journal December 1994
Keratinocyte Growth Factor: A Fibroblast Growth Factor Family Member with Unusual Target Cell Specificity journal December 1991
The human FGF-5 oncogene encodes a novel protein related to fibroblast growth factors. journal August 1988
FGF-18, a Novel Member of the Fibroblast Growth Factor Family, Stimulates Hepatic and Intestinal Proliferation journal October 1998
Augmentation of osseous phenotypes in vivo with a synthetic peptide journal January 2007
Constitutively Active BMP Type I Receptors Transduce BMP-2 Signals without the Ligand in C2C12 Myoblasts journal September 1997
Peptide Synthesis via Fragment Condensation book November 1994
Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis journal April 2000
Influence of BMPs on the Formation of Osteoblastic Lesions in Metastatic Prostate Cancer journal August 2005
Cloning and characterization of a human type II receptor for bone morphogenetic proteins. journal August 1995
Hydroxyapatite Granule Graft Combined With Recombinant Human Bone Morphogenic Protein-2 for Solid Lumbar Fusion journal January 2002
Poly(L-lysine) has different membrane transport and drug-carrier properties when complexed with heparin. journal December 1981
Powers and Pitfalls in Sequence Analysis: The 70% Hurdle journal April 2000
MADR1, a MAD-Related Protein That Functions in BMP2 Signaling Pathways journal May 1996
Errors in genome annotation journal April 1999
Cloning and Characterization of a cDNA Encoding a Novel Fibroblast Growth Factor Preferentially Expressed in Human Heart journal February 1999
Local Delivery of Basic Fibroblast Growth Factor (bFGF) Using Adsorbed Silyl-heparin, Benzyl-bis(dimethylsilylmethyl)oxycarbamoyl-heparin journal September 2002
Evaluation of Carriers of Bone Morphogenetic Protein for Spinal Fusion journal January 2001
Human keratinocyte growth factor activity on proliferation and differentiation of human keratinocytes: Differentiation response distinguishes KGF from EGF family journal August 1990
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand journal March 1999
Design of Peptides with High Affinities for Heparin and Endothelial Cell Proteoglycans journal March 2000
Peptide surface modification of poly(tetrafluoroethylene-co-hexafluoropropylene) enhances its interaction with central nervous system neurons journal October 1998
[1] Concept and early development of solid-phase peptide synthesis book January 1997
Synthesis of Native Proteins by Chemical Ligation journal June 2000
Protein annotation: detective work for function prediction journal June 1998
Multiple peptide synthesis journal April 1995
From genes to protein structure and function: novel applications of computational approaches in the genomic era journal January 2000
A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF journal February 1991
Growth factor delivery for bone tissue repair: an update journal November 2004
Basic fibroblast growth factor and bone induction in rats journal January 1993
Involvement of bone morphogenic protein‐2 (BMP‐2) in the pathological ossification process of the spinal ligament journal October 2001
Synthetic peptide F2A4-K-NS mimics fibroblast growth factor-2 in vitro and is angiogenic in vivo journal May 2006
Identification and characterization of a novel member of the fibroblast growth factor family journal May 1998
Evolutionary grouping of the transforming growth factor-β superfamily journal April 1992
Go hunting in sequence databases but watch out for the traps journal October 1996
Mitogenic properties of a new endothelial cell growth factor related to pleiotrophin journal October 1991
Smads as transcriptional co-modulators journal April 2000
FGF-20, a Novel Neurotrophic Factor, Preferentially Expressed in the Substantia Nigra Pars Compacta of Rat Brain journal October 2000
Designing Biomaterials to Direct Biological Responses journal June 1999
Additivity of mutational effects in proteins journal September 1990
A synthetic, bioactive PDGF mimetic with binding to both α-PDGF and β-PDGF receptors journal January 2007
Role of heparan sulfate in fibroblast growth factor signalling: a structural view journal September 2001
Bone Morphogenetic Proteins: From Basic Science to Clinical Applications journal January 2001
Activation of osteo-progenitor cells by a novel synthetic peptide derived from the bone morphogenetic protein-2 knuckle epitope journal September 2003
Fibroblasts expressing Sonic hedgehog induce osteoblast differentiation and ectopic bone formation journal March 1997
Laparoscopic Anterior Lumbar Interbody Fusion With rhBMP-2: A Prospective Study of Clinical and Radiographic Outcomes journal January 2001
Stimulatory Effects of Basic Fibroblast Growth Factor and Bone Morphogenetic Protein-2 on Osteogenic Differentiation of Rat Bone Marrow-Derived Mesenchymal Stem Cells journal October 1997
Structure and Sequence of HumanFGF8 journal July 1996
Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth journal August 1989
Semirational design of a potent, artificial agonist of fibroblast growth factor receptors
  • Ballinger, Marcus D.; Shyamala, Venkatakrishna; Forrest, Louise D.
  • Nature Biotechnology, Vol. 17, Issue 12, p. 1199-1204 https://doi.org/10.1038/70746
journal December 1999
A Functional Fibroblast Growth Factor-1 Immunoglobulin Fusion Protein journal June 1998
Structure and Expression of the mRNA Encoding a Novel Fibroblast Growth Factor, FGF-18 journal July 1998
Overview of Bone Morphogenetic Proteins journal January 2002
Growing better blood vessels journal November 2001
Identification of a novel fibroblast growth factor, FGF-22, preferentially expressed in the inner root sheath of the hair follicle journal February 2001
A Recombinant Human TGF-β1 Fusion Protein with Collagen-Binding Domain Promotes Migration, Growth, and Differentiation of Bone Marrow Mesenchymal Cells journal August 1999
Time for treating bone fracture using rhBMP-2: A randomised placebo controlled mouse fracture trial journal May 2005
Specific Activation of the p38 Mitogen-activated Protein Kinase Signaling Pathway and Induction of Neurite Outgrowth in PC12 Cells by Bone Morphogenetic Protein-2 journal September 1999
MDS1/EVI1 enhances TGF-β1 signaling and strengthens its growth-inhibitory effect, but the leukemia-associated fusion protein AML1/MDS1/EVI1, product of the t(3;21), abrogates growth-inhibition in response to TGF-β1 journal March 1999
Sonic hedgehog is involved in osteoblast differentiation by cooperating with BMP-2 journal October 2002
The NH2-terminal region of the active domain of sonic hedgehog is necessary for its signal transduction journal March 1999
The Mode of Bone Morphogenetic Protein (BMP) Receptor Oligomerization Determines Different BMP-2 Signaling Pathways journal November 2001
BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II journal July 2000
Alginate hydrogel linked with synthetic oligopeptide derived from BMP-2 allows ectopic osteoinductionin vivo journal June 2000
Tandem Ligation of Multipartite Peptides with Cell-Permeable Activity journal January 2003
Use of Recombinant Human Bone Morphogenetic Protein-2 in Spinal Fusion Applications journal January 2002
Identification of a Novel Fibroblast Growth Factor, FGF-23, Preferentially Expressed in the Ventrolateral Thalamic Nucleus of the Brain journal October 2000
BMP signaling components are expressed in human fracture callus journal September 2003
Endothelial Apoptosis as the Primary Lesion Initiating Intestinal Radiation Damage in Mice journal July 2001
Safety Profile for the Clinical Use of Bone Morphogenetic Proteins in the Spine journal January 2002
Identification of a cyclic peptide inhibitor of platelet-derived growth factor-BB receptor-binding and mitogen-induced DNA synthesis in human fibroblasts journal August 1997
Design and Chemical Synthesis of a Homogeneous Polymer-Modified Erythropoiesis Protein journal February 2003
Prolonged ectopic calcification induced by BMP-2-derived synthetic peptide journal January 2004

Similar Records

Dual chain synthetic heparin-binding growth factor analogs
Patent · Tue Oct 06 00:00:00 EDT 2009 · OSTI ID:1040008

Synthetic heparin-binding factor analogs
Patent · Tue Apr 20 00:00:00 EDT 2010 · OSTI ID:1040008

Synthetic heparin-binding growth factor analogs
Patent · Tue Jan 23 00:00:00 EST 2007 · OSTI ID:1040008

Related Subjects